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b Department of Cardiothoracic and Vascular Surgery, Skejby University Hospital, Aarhus, DenmarkIn this edition of the European Journal of Vascular and
Endovascular Surgery, Balm et al. have performed an
excellent state-of-the-art review of the endovascular treat-
ment of ruptured abdominal aortic aneurysms (rAAA) e so
called REVAR.1 This review is based on separate analyses of
randomized controlled trials (RCTs), observational studies
and administrative registries of rAAA repair, and shows a
non-signiﬁcant relative risk reduction of about 10% in 30
day- and/or in-hospital postoperative mortality in favour of
REVAR. This is in contrast to the observational studies and
administrative registries which demonstrate a signiﬁcant
relative risk reduction of about 50% - even after adjustment
for hemodynamic instability in a subgroup analysis. The
authors interpret the differing results as being caused by
selection bias and residual confounding, which may at least
be a part of the explanation, but selection bias could also
point towards the null hypothesis of the RCTs. Such selec-
tion bias could be a result of relatively more stable condi-
tions than in real life, giving time to gain informed consent,
and for trial preparation, etc. Such patients may easily have
a much better prognosis, and from a logical point of view
the worse the clinical status of the patient, the better a
minimally invasive treatment should be compared with
major surgery. So existing RCTs may not have evaluated
cases in which REVAR might be potentially superior in un-
stable patients who could beneﬁt from an occlusive aortic
balloon and REVAR instead of major surgery with fast aortic
clamping through a large laparotomy incision. Observational
studies and registries without doubt include such cases, as
REVAR is increasingly employed. Consequently, in addition
to evaluating the efﬁcacy of REVAR in selective RCTs, a
necessary and more relevant way from a patient- and so-
ciety perspective, is to evaluate the population-based
effectiveness of having two methods instead of one, for
treating ruptured AAA. This requires evaluation of the
overall mortality of ruptured AAA at population level and at
hospital level with and without REVAR. However, this meta-
analysis cannot answer this, nor can it answer whether theDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2014.03.003
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http://dx.doi.org/10.1016/j.ejvs.2014.03.007REVAR option increases the proportion receiving repair. It is
not just postoperative survival that may be improved, but
the option of treatment by REVAR may also increase the
proportion being offered repair leading to increased rupture
survival.
Nevertheless, based on the RCTs, the authors of the
current review and meta-analysis conclude correctly that
REVAR is not inferior to open repair for short-term survival,
but in terms of the comparison, cost is of major importance,
and there have been reports indicating that length of stay in
intensive care, use of blood products, and total length of
stay, are signiﬁcantly reduced by REVAR.2 From the cost
perspective, this could make REVAR more attractive than
open repair. However, these reports are based on obser-
vational studies and may thus be subject to selection bias.
Hopefully, the investigators behind the existing RCTs will be
able to address this question. Nevertheless, the health
resource consequences of introducing REVAR must also be
evaluated both at population and hospital level before a full
view can be taken. However, it must be assumed that in a
situation of equal cost effectiveness, the minimally invasive
procedure will probably be preferred by the patients, their
relatives, professionals, and health administrators. This
creates a novel and challenging situation, as a 24-hour
quality service for both REVAR and open repair performed
by experienced surgeons and interventionists, who need to
perform a minimal volume of procedures to maintain
acceptable experience, will be difﬁcult to achieve in all
vascular departments because of cost and the number of
available specialists.3,4REFERENCES
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